The authors additionally demonstrated that COMMD9 attenuated p53 signalling and through its interaction with TFDP1, COMMD9 promoted TFDP1/E2F1 activation in NSCLC.20 This evidence concerns the gene TFDP1 and non-small cell lung carcinoma.